1. Home
  2. BWB vs LXRX Comparison

BWB vs LXRX Comparison

Compare BWB & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgewater Bancshares Inc.

BWB

Bridgewater Bancshares Inc.

HOLD

Current Price

$17.60

Market Cap

507.5M

Sector

Finance

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.63

Market Cap

547.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWB
LXRX
Founded
2005
1995
Country
United States
United States
Employees
325
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
507.5M
547.4M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
BWB
LXRX
Price
$17.60
$1.63
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$22.33
$3.97
AVG Volume (30 Days)
55.1K
2.3M
Earning Date
01-01-0001
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.25
EPS
N/A
N/A
Revenue
N/A
$31,081,000.00
Revenue This Year
$24.57
$56.61
Revenue Next Year
$12.35
N/A
P/E Ratio
$12.97
N/A
Revenue Growth
N/A
2481.48
52 Week Low
$11.93
$0.32
52 Week High
$20.30
$1.83

Technical Indicators

Market Signals
Indicator
BWB
LXRX
Relative Strength Index (RSI) 36.01 63.93
Support Level $15.98 $1.08
Resistance Level $19.26 $1.65
Average True Range (ATR) 0.64 0.11
MACD -0.16 0.02
Stochastic Oscillator 17.99 72.63

Price Performance

Historical Comparison
BWB
LXRX

About BWB Bridgewater Bancshares Inc.

Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: